UNDERSTANDING THE ROLES OF RNA POLYMERASE I IN TRANSCRIPTION AND BEYOND
了解 RNA 聚合酶 I 在转录及其他方面的作用
基本信息
- 批准号:10402822
- 负责人:
- 金额:$ 43.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AffectBiochemicalBiologyBiophysicsCancer ControlCell ProliferationCell SurvivalDNA Polymerase IDNA Polymerase IIDNA Polymerase IIIDNA-Directed RNA PolymeraseDevelopmentEnzymesEukaryotic CellFoundationsFutureGene ExpressionGeneticGenetic TranscriptionGenomicsGoalsMessenger RNAMethodologyNuclearPolymeraseProkaryotic CellsPropertyRNARNA Polymerase IRNA chemical synthesisRNA, Ribosomal, 5SRibosomal DNARibosomal RNARibosomesRoleTherapeuticTranscriptional RegulationTransfer RNAanti-cancercell growthchemotherapyinhibitornoveltargeted treatmenttherapeutic targettranscription factor
项目摘要
Eukaryotic cells deploy at least three multisubunit, DNA-dependent RNA polymerases to
express the robust variety of RNAs required for cell survival and proliferation. In contrast to
prokaryotic cells which express a single RNA polymerase, eukaryotic RNA polymerases have
evolved into specialized cellular roles. RNA polymerase I (Pol I) synthesizes the majority of
ribosomal RNA, Pol II synthesizes messenger RNA and most regulatory RNAs, whereas Pol III
synthesizes transfer RNA and the 5S ribosomal RNA. While this "division of labor" among the
nuclear Pols has been appreciated for many years, substantial gaps in our understanding of the
functional divergence between the eukaryotic RNA polymerases remain. How do the enzymatic
properties of these enzymes differ? How do these functional differences influence regulation of
transcription by associated transcription factors? How do divergent enzymatic properties of the
Pols impact their unique cellular roles? The answers to these questions are fundamentally
important for understanding eukaryotic biology.
It is well established that the rate of ribosome synthesis is proportional to the rates of cell
growth and proliferation. As a consequence, several labs around the world seek novel inhibitors
of ribosome synthesis as potential anticancer chemotherapy agents. Since transcription of the
ribosomal DNA by Pol I is the first, rate-limiting step in ribosome synthesis, Pol I has emerged
as a key target for the development these inhibitors. In order to selectively inhibit one RNA
polymerase without affecting the others, it is crucial to understand the fundamental properties of
the enzymes as well as the cellular mechanisms by which the enzymes are controlled. Thus,
defining Pol I activity and its cellular roles has immediate translational value.
By defining the landscape of eukaryotic transcription and the many cellular roles of Pol I, this
project will reveal answers to fundamental questions in evolutionary biology while informing
ongoing studies aimed at therapeutic targeting of ribosomal RNA synthesis. To reach these
goals, our lab has developed a robust platform of experimental approaches including
biochemical, biophysical, genetic, and genomic methodologies. We have pioneered the
development of both the experimental and analytical strategies required to rigorously and
thoroughly define the functional properties of RNA polymerase I. The overall goal of this project
is to leverage these experimental strengths to impact our overall understanding of eukaryotic
gene expression and to lay the foundation for ongoing and future studies aimed at therapeutic
inhibition of Pol I.
真核细胞部署至少三种多亚基DNA依赖性RNA聚合酶,
表达细胞存活和增殖所需的多种RNA。相比
表达单个RNA聚合酶的原核细胞,真核RNA聚合酶具有
进化成专门的细胞角色。RNA聚合酶I(Pol I)合成大部分RNA聚合酶。
Pol II合成信使RNA和大多数调节RNA,而Pol III合成信使RNA和大多数调节RNA。
合成转移RNA和5S核糖体RNA。虽然这种“分工”之间的
多年来,核政策一直受到重视,我们对核政策的理解存在巨大差距。
真核生物RNA聚合酶之间的功能差异仍然存在。酶是如何
这些酶的性质不同吗?这些功能上的差异是如何影响
转录相关的转录因子?不同的酶性质是如何
Pos影响其独特的细胞作用?这些问题的答案基本上是
对理解真核生物学很重要。
众所周知,核糖体的合成速率与细胞的增殖速率成正比。
生长和增殖。因此,世界各地的一些实验室正在寻找新的抑制剂
作为潜在的抗癌化疗药物。自转录的
Pol I的核糖体DNA是核糖体合成的第一个限速步骤,Pol I已经出现
作为开发这些抑制剂的关键目标。为了选择性地抑制一种RNA
在不影响其他聚合酶的情况下,了解聚合酶的基本性质至关重要。
酶以及控制酶的细胞机制。因此,在本发明中,
定义Pol I活性及其细胞作用具有直接的翻译价值。
通过定义真核转录的景观和Pol I的许多细胞作用,
该项目将揭示进化生物学基本问题的答案,同时为人类提供信息。
正在进行的研究旨在核糖体RNA合成的治疗靶向。达到这些
为了实现这一目标,我们的实验室开发了一个强大的实验方法平台,包括
生物化学、生物物理学、遗传学和基因组学方法。我们开创了
制定实验和分析策略,
彻底定义RNA聚合酶I的功能特性。本项目的总体目标
是利用这些实验优势来影响我们对真核生物的整体理解,
基因表达,并为正在进行的和未来的研究奠定基础,旨在治疗
抑制Pol I。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Alan Schneider其他文献
David Alan Schneider的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Alan Schneider', 18)}}的其他基金
UNDERSTANDING THE ROLES OF RNA POLYMERASE I IN TRANSCRIPTION AND BEYOND
了解 RNA 聚合酶 I 在转录及其他方面的作用
- 批准号:
10159609 - 财政年份:2021
- 资助金额:
$ 43.14万 - 项目类别:
UNDERSTANDING THE ROLES OF RNA POLYMERASE I IN TRANSCRIPTION AND BEYOND
了解 RNA 聚合酶 I 在转录及其他方面的作用
- 批准号:
10618920 - 财政年份:2021
- 资助金额:
$ 43.14万 - 项目类别:
Control of RNA polymerase I transcription initiation and elongation
RNA 聚合酶 I 转录起始和延伸的控制
- 批准号:
9761542 - 财政年份:2009
- 资助金额:
$ 43.14万 - 项目类别:
Control of RNA polymerase I transcription initiation and elongation
RNA 聚合酶 I 转录起始和延伸的控制
- 批准号:
8114121 - 财政年份:2009
- 资助金额:
$ 43.14万 - 项目类别:
Control of RNA polymerase I transcription initiation and elongation
RNA 聚合酶 I 转录起始和延伸的控制
- 批准号:
8758157 - 财政年份:2009
- 资助金额:
$ 43.14万 - 项目类别:
Control of RNA polymerase I transcription initiation and elongation
RNA 聚合酶 I 转录起始和延伸的控制
- 批准号:
8511697 - 财政年份:2009
- 资助金额:
$ 43.14万 - 项目类别:
Control of RNA polymerase I transcription initiation and elongation
RNA 聚合酶 I 转录起始和延伸的控制
- 批准号:
8908019 - 财政年份:2009
- 资助金额:
$ 43.14万 - 项目类别:
Control of RNA polymerase I transcription initiation and elongation
RNA 聚合酶 I 转录起始和延伸的控制
- 批准号:
8300935 - 财政年份:2009
- 资助金额:
$ 43.14万 - 项目类别:
Mentored Experiences in Research, Instruction and Teaching (MERIT) Program
研究、指导和教学 (MERIT) 项目的指导经验
- 批准号:
10686282 - 财政年份:2009
- 资助金额:
$ 43.14万 - 项目类别:
Control of RNA polymerase I transcription initiation and elongation
RNA 聚合酶 I 转录起始和延伸的控制
- 批准号:
7938927 - 财政年份:2009
- 资助金额:
$ 43.14万 - 项目类别:
相似海外基金
Elucidating the molecular basis and expanding the biological applications of the glycosyltransferases using biochemical and structural biology approaches
利用生化和结构生物学方法阐明糖基转移酶的分子基础并扩展其生物学应用
- 批准号:
23K14138 - 财政年份:2023
- 资助金额:
$ 43.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Utilizing the power of synthetic biology and De Novo design for the overexpression and biochemical stabilization of KCNA6 or Kv1.6 potassium channels in the E. coli expression system
利用合成生物学和 De Novo 设计的力量,实现大肠杆菌表达系统中 KCNA6 或 Kv1.6 钾通道的过度表达和生化稳定
- 批准号:
10666856 - 财政年份:2023
- 资助金额:
$ 43.14万 - 项目类别:
Developing synthetic chemical biology strategies for biochemical investigations and biomedical applications
开发用于生化研究和生物医学应用的合成化学生物学策略
- 批准号:
10623497 - 财政年份:2023
- 资助金额:
$ 43.14万 - 项目类别:
NSF Postdoctoral Fellowship in Biology FY 2022: Defining the biochemical mechanisms of microtubule shrinking and nucleation by combining innovative experiments and simulations
2022 财年 NSF 生物学博士后奖学金:通过结合创新实验和模拟来定义微管收缩和成核的生化机制
- 批准号:
2209298 - 财政年份:2022
- 资助金额:
$ 43.14万 - 项目类别:
Fellowship Award
An Integrated Biochemical and Structural Approach to Delineating the Biology of EWSR1
描述 EWSR1 生物学的综合生化和结构方法
- 批准号:
10665058 - 财政年份:2021
- 资助金额:
$ 43.14万 - 项目类别:
An Integrated Biochemical and Structural Approach to Delineating the Biology of EWSR1 - Multi-Mode Detection and Imaging of Biomolecular Condensates.
描述 EWSR1 生物学的综合生化和结构方法 - 生物分子凝聚物的多模式检测和成像。
- 批准号:
10797858 - 财政年份:2021
- 资助金额:
$ 43.14万 - 项目类别:
An Integrated Biochemical and Structural Approach to Delineating the Biology of EWSR1
描述 EWSR1 生物学的综合生化和结构方法
- 批准号:
10298663 - 财政年份:2021
- 资助金额:
$ 43.14万 - 项目类别:
Physiological and biochemical insights into the biology of marine vertebrates and the ecosystems within which they function
对海洋脊椎动物及其功能的生态系统的生物学的生理和生化见解
- 批准号:
RGPIN-2015-04374 - 财政年份:2019
- 资助金额:
$ 43.14万 - 项目类别:
Discovery Grants Program - Individual
Physiological and biochemical insights into the biology of marine vertebrates and the ecosystems within which they function
对海洋脊椎动物及其功能的生态系统的生物学的生理和生化见解
- 批准号:
RGPIN-2015-04374 - 财政年份:2018
- 资助金额:
$ 43.14万 - 项目类别:
Discovery Grants Program - Individual
Physiological and biochemical insights into the biology of marine vertebrates and the ecosystems within which they function
对海洋脊椎动物及其功能的生态系统的生物学的生理和生化见解
- 批准号:
RGPIN-2015-04374 - 财政年份:2017
- 资助金额:
$ 43.14万 - 项目类别:
Discovery Grants Program - Individual